VLADMIVA to Invest 500 Million Rubles in Expanding Pharmaceutical Production

On June 3, at the St. Petersburg International Economic Forum, the CEO of the VLADMIVA Group of Companies and the Acting Governor of the Tver Region signed an agreement to implement an investment project.

In 2024, VLADMIVA acquired the Tver Pharmaceutical Factory, the largest manufacturer of herbal medicines. The holding company will now invest 500 million rubles in the pharmaceutical factory to implement advanced technologies and its own developments.
Vitaly Korolev, Acting Governor of the Tver Region, and Vladimir Chuev, CEO of the VLADMIVA Group of Companies, signed the investment project at the St. Petersburg International Economic Forum on June 3, 2026. The Tver Pharmaceutical Factory will now create more than 30 new jobs, and its production volume and product range will expand.
As Korolev noted, the company has been supplying consumers, including pensioners, with affordable medications since Soviet times. Therefore, Chuev's decision can be considered fundamentally important not only for the region but for the entire country.

The project plans to increase production from 10 million units to 12-15 million units annually. Furthermore, where possible, it plans to register new topical medications for pain relief in diseases of the nervous system, muscles, and joints, as well as injuries and swelling.

Furthermore, the parties discussed expanding support measures for SVO participants and their families through medical care.